3 results
Approved WMORecruitment stopped
Scar volume and POSAS score will be measured in the Verapamil group, these will be compared to the scar volume and POSAS score in the Kenacort+Verapamil group and the Kenacort group. In addition, complications/ adverse effects will be reported.
Approved WMOWill not start
A proof of concept study to test whether ARA 290 improves wound healing and reduces neuropathic pain in no-option patients with CLI
Approved WMORecruiting
This study has been transitioned to CTIS with ID 2023-508530-34-00 check the CTIS register for the current data. Primary objective:* To demonstrate the efficacy of alpelisib as measured by the proportion of participants randomized to alpelisib with…